glp-1 trends Agonists Weight Loss Drugs Market Report, 2025-2030 Semaglutide Prescription Rates | athenahealth

Retatrutide appears to dial down the emotional and reward aspects of eating while leaving the nutritional drive intact

After reviewing more than a dozen formularies, we noticed the following trends: Employer-sponsored benefit plans are the most likely to cover weight loss drugs, with a 2025 study showing that 19% of large firms and 43% of firms with 5,000 or more employees cover GLP-1 agonists

Adding chicken, fish, beans, or protein shakes can protect muscle mass while fat decreases

doi: 10.1016/j.isci.2024.109903

At 68 weeks, 14.1% of participants in the 9mg group reported being completely pain-free, compared to 4.2% on placebo

GLP-1s have been used to treat T2D since 2005, said Chris Schott, a senior analyst covering the U.S